Free shipping on all orders over $ 500

VU 0255035

Cat. No. M1866

All AbMole products are for research use only, cannot be used for human consumption.

VU 0255035 Structure
Size Price Availability Quantity
5mg USD 90 In stock
10mg USD 140 In stock
25mg USD 300 In stock
50mg USD 500 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

VU 0255035 is a M1 muscarinic acetylcholine receptor (mAChR) antagonist (Ki = 14.87 nM). VU 0255035 shows higher selectivity to the M1 orthosteric site than other receptor subtypes. The M(1) mAChR is of particular interest as a potential target for treatment of CNS disorders. Whole-cell patch-clamp recordings demonstrate that VU0255035 inhibits potentiation of N-methyl-D-aspartate receptor currents by the muscarinic agonist carbachol in hippocampal pyramidal cells. VU0255035 has excellent brain penetration in vivo and is efficacious in reducing pilocarpine-induced seizures in mice. VU 0255035 does not induce the severe cognitive deficits seen with nonselective mAChR antagonists and could provide a novel approach for the treatment certain of CNS disorders.

Chemical Information
Molecular Weight 432.52
Formula C18H20N6O3S2
CAS Number 1135243-19-4
Form Solid
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Sheffler et al. Mol Pharmacol. A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.

Related AChR/AChE Products
Fesoterodine fumarate

Fesoterodine fumarate (Toviaz) is a novel muscarinic receptor antagonist.

SVT-40776

SVT-40776 is a novel M3 muscarinic receptor antagonist.

Aniracetam

Aniracetam is a compound that promotes intellectual development and neuroprotection.

Biperiden hydrochloride

Biperiden (KL 373) hydrochloride is a non-selective muscarinic receptor antagonist that competitively binds to M1 muscarinic receptors, thereby inhibiting acetylcholine and enhancing dopamine signaling in the central nervous system.

Levetiracetam

Levetiracetam (UCB L059) is an antiepileptic, it is also a selective M2 muscarinic acetylcholine receptors (mAChR) inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: VU 0255035 supplier, AChR/AChE, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.